news
Immunotherapy before surgery benefits melanoma patients
In a Phase II trial, immunotherapy drug pembrolizumab significantly lowered the risk of recurrence for stage III-IV melanoma patients when given before and after surgery.
List view / Grid view
National Cancer Institute
news
Drug combination an alternative leukaemia treatment to chemotherapy
A clinical trial found that all-trans retinoic acid and arsenic trioxide is an effective treatment for acute promyelocytic leukaemia.
news
Micromotors used for the delivery of oral vaccines
Researchers have developed a method of using micromotors to deliver oral vaccines in an attempt to break away from widely used injections...
news
Taking a standard prostate cancer drug with food boosts impact
By taking Zytiga with a low-fat meal could decrease the daily dose and prevent digestive issues...
news
Z-endoxifen shows promise for breast cancer
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer...
news
FDA expands approved use of Bayer’s liver cancer treatment
2 May 2017 | By Niamh Marriott, Junior Editor
The FDA has expanded the approved use of Bayer's Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma...
news
Large study shows older breast cancer patients have worse outcomes
13 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Results showed that mortality was higher in patients over 70 who were either not tested with Oncotype DX or had a recurrence score result greater than 18...
news
Lion Biotechnologies announces publication of data from clinical study of metastatic cervical cancer patients treated with HPV-TIL
8 April 2015 | By Victoria White
Lion Biotechnologies has announced that data from a study of metastatic cervical cancer patients treated with treated with HPV-TIL has been published...
news
Advanced Cell Diagnostics awarded $1.4 million NCI Grant to develop ultrasensitive diagnostic test for B-cell lymphoma
10 October 2014 | By Advanced Cell Diagnostics, Inc
Advanced Cell Diagnostics, Inc. has been awarded a two-year, $1.4 million grant from National Cancer Institute...
news
Amgen joins The National Cancer Institute and Research Partners to help accelerate development of personalized treatment approaches for squamous cell lung cancer
17 June 2014 | By Amgen
Amgen announced that it will collaborate with the National Cancer Institute (NCI), part of the National Institutes of Health, and other public and private sector partners on the Lung Master Protocol (Lung-MAP)...
news
Major study reveals new ways to classify cancer
27 September 2013 | By Cancer Research UK
A US-led initiative to map the molecular similarities and differences of thousands of tumours has revealed new ways to classify cancer...
